{
    "code": "02021688",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021688",
    "time": "2015-08-23 10:24:04",
    "許可證字號": "衛署藥輸字第021688號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/09\/01",
    "註銷理由": "自請註銷",
    "有效日期": "91\/05\/13",
    "發證日期": "86\/05\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202168809",
    "中文品名": "注射液２０公絲\/２公撮",
    "英文品名": "METHOTREXATE INJECTION 20MG\/2ML \"DBL\"",
    "適應症": "白血病、絨毛性腫瘍、自覺及他覺症狀之緩解。",
    "劑型": "270注射劑",
    "包裝": "盒裝 小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1316201100  瑞帝有限公司",
    "申請商地址": "台北巿建國北路二段８５號２樓",
    "主製造廠": {
        "製造廠名稱": "F020031100  F.H. FAULDING CO., LTD. (TRADING AS DAVID BULL LABORATORIES)",
        "製造廠廠址": "1-23 LEXIA PLACE, MULGRAVE VICTORIA 3170 AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": []
}